Literature DB >> 24485294

[Incidence and mortality of urological cancers in 2012 in France].

X Rébillard1, P Grosclaude2, N Leone3, M Velten4, G Coureau5, A Villers6, J Irani6, T Lebret6, J Rigaud6, C Pfister6, J-J Patard6, P Richaud6, L Salomon6, P Coloby6, M Soulié6.   

Abstract

OBJECTIVES: Present national estimations of the incidence and mortality trends in urological cancers in France between 1980 and 2012.
MATERIAL AND METHODS: Francim database and French Register of Cancers.
RESULTS: Analysis of the current data shows a regular increase of the incidence of renal cancer in men and women (7,781 cases in men and 3,792 in women in 2012). For bladder cancer, trends are divergent. There is a small reduction in incidence for men and an increase for women (9,549 cases in men and 2,416 in women in 2012). Testicular cancer is still increasing slightly (2,317 incidental cases in 2012). The incidence of prostate cancer experienced a huge increase up until 2005, and thereafter it decreased sharply, though it is difficult to discern whether this drop (which was observed up until 2008) continued at the same rate after that point (56,841 incidences in 2012 based on the rates calculated for 2009).
CONCLUSION: The analyses by organ database show that there are significant variations in the incidence of urological cancers, particularly for prostate cancer, which shows that both the natural history of urological tumours and the methods of detection have an impact on incidence.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Cancer de la prostate; Cancer de la vessie; Cancer du rein; Cancer du testicule; Epidemiology; Incidence; Prostate cancer; Renal cancer; Testis cancer; Épidémiologie

Mesh:

Year:  2013        PMID: 24485294     DOI: 10.1016/S1166-7087(13)70047-2

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  3 in total

1.  HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer.

Authors:  A L Couderc; X Muracciole; E Nouguerede; D Rey; S Schneider; P Champsaur; E Lechevallier; L Lalys; P Villani
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

2.  Cancer incidence in Spain, 2015.

Authors:  J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

3.  Prostate cancer: net survival and cause-specific survival rates after multiple imputation.

Authors:  Adeline Morisot; Faïza Bessaoud; Paul Landais; Xavier Rébillard; Brigitte Trétarre; Jean-Pierre Daurès
Journal:  BMC Med Res Methodol       Date:  2015-07-28       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.